XML 25 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($)
Class A
Common Stock
Class B
Common Stock
Preferred Convertible Series A Shares
Preferred Convertible Series B Shares
Preferred Convertible Series C Shares
Preferred Convertible Series F Shares
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Other Comprehensive Income
Stockholders Equity
Noncontrolling Interest
Total
Balance at Jul. 31, 2020     $ 101 $ 86,364 $ (88,697) $ 1 $ (2,231) $ (382) $ (2,613)
Balance (in Shares) at Jul. 31, 2020     225,000 407,477 101,323,590            
Amortization of employee stock options     135 135 135
Common stock issued for services, to employees     $ 8 257 265 265
Common stock issued for services, to employees (in Shares)             7,858,820            
Common stock issued for services     $ 4 219 223 223
Common stock issued for services (in Shares)             4,250,000            
Common stock issued for debt conversion and settlement     $ 21 407 428 428
Common stock issued for debt conversion and settlement (in Shares)             21,275,629            
Common stock issued for exercise of warrants     $ 1 33 34 34
Common stock issued for exercise of warrants (in Shares)             330,000            
Common stock issued, extension of debt     $ 1 59 60 60
Common stock issued, extension of debt (in Shares)             400,000            
Convertible Series B Preferred stock issued for debt settlement     18 18 18
Convertible Series B Preferred stock issued for debt settlement (in Shares)       17,965                  
Convertible Series C Preferred stock issued for AP settlement     554 554 554
Convertible Series C Preferred stock issued for AP settlement (in Shares)     55,400              
Super Voting Preferred Stock Series F    
Super Voting Preferred Stock Series F (in Shares)           100              
Derivative liability resolved to APIC due to note conversion     588 588 588
Common stock issued concurrent with convertible debt     $ 2 145 147 147
Common stock issued concurrent with convertible debt (in Shares)     2,100,000            
Beneficial conversion feature on convertible debt     282 282 282
Common stock issued for settlement of accounts payable     $ 1 59 60 60
Common stock issued for settlement of accounts payable (in Shares)             1,000,000            
Dividends declared     (20) (20) (20)
Net income (loss)     (16,683) (16,683) (332) (17,015)
Balance at Jul. 31, 2021     $ 139 89,100 (105,380) 1 (16,140) (714) (16,854)
Balance (in Shares) at Jul. 31, 2021     225,000 425,442 55,400 100 138,538,039            
Balance at Feb. 17, 2021                
Balance (in Shares) at Feb. 17, 2021                      
Net income (loss)           (547)       (547)
Balance at Mar. 31, 2021           (547)       (547)
Balance (in Shares) at Mar. 31, 2021                      
Balance at Feb. 17, 2021                
Balance (in Shares) at Feb. 17, 2021                      
Net income (loss)                         (1,104,242)
Balance at Sep. 30, 2021 $ 16 $ 316           (18,837,979)       (18,837,647)
Balance (in Shares) at Sep. 30, 2021 158,125 3,162,500                      
Balance at Feb. 17, 2021                
Balance (in Shares) at Feb. 17, 2021                      
Class B common stock issued to Sponsor $ 316           24,684       25,000
Class B common stock issued to Sponsor (in Shares)   3,162,500                      
Proceeds received in excess of fair value of private warrants           1,084,163       1,084,163
Issuance of shares to underwriter representative at fair value $ 16           1,454,418       1,454,434
Issuance of shares to underwriter representative at fair value (in Shares) 158,125                      
Remeasurement of common stock subject to possible redemption               (2,563,265) (17,733,737)       (20,297,002)
Net income (loss)           5,906,214       5,906,214
Balance at Dec. 31, 2021 $ 16 $ 316           (11,827,524)       (11,827,192)
Balance (in Shares) at Dec. 31, 2021 158,125 3,162,500                      
Balance at Mar. 31, 2021           (547)       (547)
Balance (in Shares) at Mar. 31, 2021                      
Class B common stock issued to Sponsor   $ 316           24,684         25,000
Class B common stock issued to Sponsor (in Shares)   3,162,500                      
Net income (loss)           (85)       (85)
Balance at Jun. 30, 2021 $ 316           24,684 (632)       24,368
Balance (in Shares) at Jun. 30, 2021 3,162,500                      
Issuance of 158,125 shares to underwriter representative at fair value $ 16           1,454,418       1,454,434
Issuance of 158,125 shares to underwriter representative at fair value (in Shares) 158,125                      
Proceeds received in excess of fair value of private warrants           1,084,163       1,084,163
Net income (loss)               (1,103,610)       (1,103,610)
Accretion of Class A common stock subject to possible redemption           (2,563,265) (17,733,737)       (20,297,002)
Balance at Sep. 30, 2021 $ 16 $ 316           (18,837,979)       (18,837,647)
Balance (in Shares) at Sep. 30, 2021 158,125 3,162,500                      
Balance at Jul. 31, 2021     $ 139 89,100 (105,380) 1 (16,140) (714) (16,854)
Balance (in Shares) at Jul. 31, 2021     225,000 425,442 55,400 100 138,538,039            
Amortization of employee stock options     24 24 24
Common stock issued concurrent with convertible debt     38 38 38
Common stock issued concurrent with convertible debt (in Shares)             600,000            
Dividends declared     (5) (5) (5)
Net income (loss)     2,424 2,424 (158) 2,266
Balance at Oct. 31, 2021     $ 139 89,157 (102,956) 1 (13,659) (872) (14,531)
Balance (in Shares) at Oct. 31, 2021     225,000 425,442 55,400 100 139,138,039            
Balance at Jul. 31, 2021     $ 139 89,100 (105,380) 1 (16,140) (714) (16,854)
Balance (in Shares) at Jul. 31, 2021     225,000 425,442 55,400 100 138,538,039            
Amortization of employee stock options     98 98 98
Common stock issued for services     $ 1 125 126 126
Common stock issued for services (in Shares)             1,500,000            
Common stock issued for debt extension     $ 1 64 65 65
Common stock issued for debt extension (in Shares)             550,000            
Common stock issued concurrent with convertible debt     $ 1 119 120 120
Common stock issued concurrent with convertible debt (in Shares)     1,500,000            
Dividends declared     (19) (19) (19)
Net income (loss)     (8,013) (8,013) (1,341) (9,354)
Balance at Jul. 31, 2022     $ 142 89,487 (113,393) 1 (23,763) (2,055) (25,818)
Balance (in Shares) at Jul. 31, 2022     225,000 425,442 55,400 100 142,088,039            
Balance at Dec. 31, 2021 $ 16 $ 316           (11,827,524)       (11,827,192)
Balance (in Shares) at Dec. 31, 2021 158,125 3,162,500                      
Net income (loss)           3,976,791       3,976,791
Balance at Mar. 31, 2022 $ 16 $ 316           (7,850,733)       (7,850,401)
Balance (in Shares) at Mar. 31, 2022 158,125 3,162,500                      
Balance at Dec. 31, 2021 $ 16 $ 316           (11,827,524)       (11,827,192)
Balance (in Shares) at Dec. 31, 2021 158,125 3,162,500                      
Net income (loss)                         5,369,223
Balance at Sep. 30, 2022 $ 16 $ 316           (8,059,563)       (8,059,231)
Balance (in Shares) at Sep. 30, 2022 158,125 3,162,500                      
Balance at Mar. 31, 2022 $ 16 $ 316           (7,850,733)       (7,850,401)
Balance (in Shares) at Mar. 31, 2022 158,125 3,162,500                      
Net income (loss)           1,959,110       1,959,110
Balance at Jun. 30, 2022 $ 16 $ 316           (5,891,623)       (5,891,291)
Balance (in Shares) at Jun. 30, 2022 158,125 3,162,500                      
Net income (loss)           (566,677)       (566,677)
Accretion of Class A common stock subject to possible redemption           (1,601,263)       (1,601,263)
Balance at Sep. 30, 2022 $ 16 $ 316           (8,059,563)       (8,059,231)
Balance (in Shares) at Sep. 30, 2022 158,125 3,162,500                      
Balance at Jul. 31, 2022     $ 142 89,487 (113,393) 1 (23,763) (2,055) (25,818)
Balance (in Shares) at Jul. 31, 2022     225,000 425,442 55,400 100 142,088,039            
Amortization of employee stock options     23 23 23
Common stock issued for conversion of Series A Convertible Preferred stock     7 7 7
Common stock issued for conversion of Series A Convertible Preferred stock (in Shares)     (25,000) 105,723            
Common stock issued for exercise of warrants     21 21 21
Common stock issued for exercise of warrants (in Shares)             160,628            
Common stock issued for debt extension     $ 2 247 249 249
Common stock issued for debt extension (in Shares)             2,060,000            
Common stock issued concurrent with convertible debt     $ 1 94 95 95
Common stock issued concurrent with convertible debt (in Shares)     650,000            
Dividends declared     (4) (4) (4)
Net income (loss)     (4,984) (4,984) (161) (5,145)
Balance at Oct. 31, 2022     $ 145 $ 89,875 $ (118,377) $ 1 $ (28,356) $ (2,216) $ (30,572)
Balance (in Shares) at Oct. 31, 2022     200,000 425,442 55,400 100 145,064,390